| Literature DB >> 30816849 |
Fernando Dias Correia1,2, André Nogueira1, Ivo Magalhães1, Joana Guimarães1, Maria Moreira1, Isabel Barradas1, Maria Molinos1, Laetitia Teixeira3,4,5, José Tulha6, Rosmaninho Seabra6, Jorge Lains7, Virgílio Bento1,8.
Abstract
BACKGROUND: Physical rehabilitation is recommended after total knee arthroplasty (TKA). With the expected increase in TKA over the next few decades, it is important to find new ways of delivering cost-effective interventions. Technological interventions have been developed with this intent, but only preliminary evidence exists regarding their validity, with short follow-up times.Entities:
Keywords: TKA; artificial intelligence; digital physiotherapist; eHealth; home-based telerehabilitation; knee
Year: 2019 PMID: 30816849 PMCID: PMC6416534 DOI: 10.2196/13111
Source DB: PubMed Journal: JMIR Rehabil Assist Technol ISSN: 2369-2529
Figure 1System components. (A) Motion tracker setup. (I) Red tracker: over the sternal manubrium. (II) Green tracker: anterior surface of the hip. (III) Blue tracker: over the anterior tibial crest. (B) Mobile App: preparation screen. This screen is shown before each exercise and displays a video of the exercise as well as audio instructions. (C) Mobile App: execution screen. (D) Web Portal - prescription screen. This screen displays the available exercises on the left and the layout of the exercise session on the right. (E) Web Portal - results screen. In this screen, the following information is presented: date and time of the session; session duration; pain and fatigue reported by the patient through the app; and one card per exercise, showing baseline and target joint angles, wrong and incomplete repetitions, and posture errors.
Figure 2Study CONSORT diagram. CONSORT: Consolidated Standards of Reporting Trials; TKA: total knee arthroplasty.
Baseline characteristics of the study participants.
| Characteristics | Total (N=69) | Digital intervention group (N=38) | Conventional rehabilitation group (N=31) | ||
| Age (years), mean (SD) | 68.5 (7.0) | 67.3 (6.8) | 70.0 (7.2) | 0.12b | |
| Gender, female, n (%) | 54 (78.3) | 32 (84.2) | 22 (71.0) | 0.30c | |
| Operated knee - right, n (%) | 38 (55.1) | 23 (63.2) | 14 (45.2) | 0.21c | |
| Body mass index, mean (SD) | 30.9 (4.9) | 31.0 (4.5) | 30.8 (5.4) | 0.84b | |
| Smoking, n (%) | 8 (11.6) | 4 (10.5) | 4 (12.9) | 1.00d | |
| Hypertension, n (%) | 48 (69.6) | 25 (65.8) | 23 (74.2) | 0.62c | |
| Diabetes, n (%) | 11 (15.9) | 7 (18.4) | 4 (12.9) | 0.74d | |
| Pulmonary disease, n (%) | 9 (13.0) | 3 (7.9) | 6 (19.4) | 0.28d | |
| Cardiac disease, n (%) | 4 (5.8) | 2 (5.3) | 2 (6.5) | 1.00d | |
| Stroke, n (%) | 0 (0) | 0 (0) | 0 (0) | N/Ae | |
| Renal disease, n (%) | 2 (1.4) | 0 (0) | 1 (3.2) | 0.45d | |
| Bleeding disorders, n (%) | 0 (0) | 0 (0) | 0 (0) | N/A | |
| ASAf class 3 or 4g, n (%) | 10 (14.5) | 5 (13.2) | 5 (16.1) | 0.74d | |
| Steroids for chronic condition, n (%) | 0 (0) | 0 (0) | 0 (0) | N/A | |
| Previous contralateral knee replacement, n (%) | 17 (24.6) | 7 (18.4) | 10 (32.3) | 0.30c | |
| Previous hip replacement, n (%) | 3 (4.3) | 3 (7.9) | 0 (0) | 0.25d | |
| Time between admission and surgery (hours) | <24 | <24 | <24 | N/A | |
| Operative time (min), mean (SD) | 62.6 (11.3) | 62.4 (9.87) | 62.8 (13.0) | 0.89b | |
| Minor adverse events before discharge, n (%) | 1 (1.4) | 0 (0) | 1 (3.2) | 0.45d | |
| Hospital length of stay (days), median (interquartile range) | 6 (1.0) | 6 (1.0) | 6 (2.0) | 0.83c | |
aMann-Whitney U test.
bIndependent samples t test.
cChi square test.
dFisher exact test.
eN/A: not applicable.
fASA: American Society of Anesthesiology.
gAmerican Society of Anesthesiology physical status classification system.
Results of the secondary outcome measure (Knee Osteoarthritis Outcome Score).
| Outcome variables | Digital intervention group, median (IQRa) | Control group, | Estimate difference between groupsc | 95% CIc | ||
| Symptoms | 34.0 (20.0) | 50.0 (29.0) | <.001 | –18.0 | –25.0 to –17.0 | |
| Pain | 33.0 (12.0) | 47.0 (24.0) | <.001 | –11.0 | –19.0 to –6.0 | |
| ADLd | 34.0 (18.0) | 41.0 (18.0) | .005 | –9.0 | –15.0 to –3.0 | |
| Sports | 0.0 (0.0) | 5.0 (8.0) | .006 | 0.0 | –5.0 to 0 | |
| Quality of life | 13.0 (19.0) | 25.0 (19.0) | .007 | –12.0 | –18.0 to 0 | |
| Symptoms | 87.5 (11.8) | 82.0 (19.5) | .01 | 9.0 | 0-15.0 | |
| Pain | 95.5 (11.8) | 86.0 (22.5) | <.001 | 11.0 | 5.0-17.0 | |
| ADL | 93.0 (8.0) | 87.0 (22.5) | .001 | 7.0 | 3.0-15.0 | |
| Sports | 30.0 (11.3) | 20.0 (7.5) | .001 | 10.0 | 5.0-15.0 | |
| Quality of life | 81.0.0 (14.5) | 56.0 (25.0) | <.001 | 19.0 | 12.0-25.0 | |
| Symptoms | 51.5 (24.25) | 25.0 (27.0) | <.001 | 25.0 | 15.0-35.0 | |
| Pain | 58.0 (12.0) | 31.0 (23.5) | <.001 | 23.0 | 15.0-31.0 | |
| ADL | 57.5 (17.8) | 35.0 (16.5) | <.001 | 20.0 | 13.0-27.0 | |
| Sports | 30.0 (11.3) | 15.0 (10.0) | <.001 | 10.0 | 10.9-15.0 | |
| Quality of life | 65.0 (22.0) | 44.0 (21.0) | <.001 | 25.0 | 18.0-37.0 | |
| Symptoms | 96.0 (15.0) | 86.0 (22.0) | .006 | 7.0 | 3.0-14.0 | |
| Pain | 100.0 (8.0) | 86.0 (23.5) | .002 | 11.0 | 3.0-16.0 | |
| ADL | 97.0 (6.0) | 87.0 (14.5) | .001 | 7.0 | 4.0-13.0 | |
| Sports | 42.5 (36.3) | 20.0 (22.5) | .003 | 15.0 | 5.0-30.0 | |
| Quality of life | 94.0 (12.0) | 63.0 (37.5) | .001 | 25.0 | 12.0-32.0 | |
| Symptoms | 60.5 (25.8) | 29.0 (33.5) | <.001 | 25.0 | 15.0-36.0 | |
| Pain | 61.0 (11.8) | 39.0 (24.0) | <.001 | 20.0 | 14.0-28.0 | |
| ADL | 58.0 (17.5) | 43.0 (23.0) | <.001 | 19.0 | 11.0-26.0 | |
| Sports | 40.0 (35.0) | 15.0 (27.5) | <.001 | 20.0 | 10.0-30.0 | |
| Quality of life | 81.0 (20.0) | 43.0 (40.5) | <.001 | 36.5 | 24.0-49.0 | |
aIQR: interquartile range.
bMann-Whitney U test.
cHodges-Lehman estimator.
dADL: activities of daily living.
Results of the primary outcome measure (Timed Up and Go score).
| Time point | Digital intervention group, median (IQRa) | Control group, | Estimated difference between groupsc | 95% CIc | |
| Baseline | 18.19 (6.2) | 15.27 (8.5) | .13 | 2.02 | –0.78 to 4.44 |
| 3 months | 7.83 (2.4) | 10.3 (3.5) | <.001 | –2.50 | –1.43 to –3.80 |
| Change from baseline to 3 months | –10.28 (5.9) | –5.23 (8.5) | .004 | –4.48 | –1.64 to –7.37 |
| 6 months | 6.86 (1.6) | 8.74 (4.0) | <.001 | –1.95 | –1.24 to –2.90 |
| Change from baseline to 6 months | –10.47 (7.2) | –5.08 (9.3) | .003 | –4.87 | –1.85 to –7.47 |
aIQR: interquartile range.
bMann-Whitney U test.
cHodges-Lehman estimator.
Results of the secondary outcome measures (knee range of motion).
| Outcome variables | Digital intervention group, mean (SD) | Control group, mean (SD) | Estimate difference between groups | 95% CI | ||
| Lying flexion | 80.7 (12.4) | 84.7 (18.7) | .34 | 4.0 | –12.2 to 4.3 | |
| Sitting flexion | 85.3 (16.0) | 90.4 (13.1) | .19 | 5.1 | –12.8 to 2.5 | |
| Standing flexion | 71.6 (20.3) | 78.8 (16.6) | .15 | 7.2 | –16.8 to 2.6 | |
| Sitting extension | 26.5 (8.4) | 24.8 (7.8) | .43 | 1.7 | –2.5 to 6.0 | |
| Lying flexion | 100.1 (12.6) | 93.3 (13.6) | .052 | 6.8 | –0.04 to 13.62 | |
| Sitting flexion | 102.5 (13.1) | 96 (11.3) | .046 | 6.5 | 0.10-12.89 | |
| Standing flexion | 95.6 (10.2) | 84.9 (10.4) | <.001 | 10.7 | 5.22-16.08 | |
| Sitting extension | 11.8 (8.3) | 19 (8.8) | .002 | –7.2 | 2.73-11.65 | |
| Lying flexion | 19.4 (15.5) | 8.7 (15.1) | .009 | 10.7 | 2.8-18.7 | |
| Sitting flexion | 17.3 (20.1) | 5.7 (14.7) | .01 | 11.6 | 2.4-20.8 | |
| Standing flexion | 23.9 (17.6) | 6.1 (14.1) | <.001 | 17.8 | 9.5-26.2 | |
| Sitting extension | –14.8 (9.0) | –5.9 (11.6) | .002 | -8.9 | –3.5 to –14.3 | |
| Lying flexion | 103.4 (10.6) | 101.5 (13.3) | .55 | 1.9 | –4.38 to 8.15 | |
| Sitting flexion | 102.5 (10.8) | 102.2 (12.3) | .93 | 0.3 | –5.77 to 6.29 | |
| Standing flexion | 97.4 (9.9) | 89.9 (11.7) | .01 | 7.5 | 1.78-13.08 | |
| Sitting extension | 7.1 (6.6) | 9.7 (5.8) | .12 | –2.6 | –5.83 to 0.64 | |
| Lying flexion | 22.7 (12.9) | 16.8 (17.4) | .15 | 5.8 | –2.1 to 13.8 | |
| Sitting flexion | 17.2 (19.1) | 11.9 (13.9) | .22 | 5.4 | –3.4 to 14.1 | |
| Standing flexion | 25.7 (20.1) | 11.2 (14.0) | .002 | 14.6 | 5.5-23.6 | |
| Sitting extension | –19.4 (8.4) | –15.1 (8.7) | .06 | –4.3 | –8.8 to 0.2 | |
aIndependent samples t test.
Repeated measures analysis. Greenhouse-Geisser correction was used for all variables.
| Outcome variables | Time | Group | Time*Group | ||||||||
| Fdf1,df2 | |||||||||||
| Timed Up and Goa | 76.406 | <.001 | 9.346 | 0.003 | 7.801 | <.001 | |||||
| Lying flexion | 42.3 | <.001 | 0.8 | 0.375 | 4.29 | 0.008 | |||||
| Sitting flexion | 24.8 | <.001 | 0.27 | 0.604 | 3.98 | 0.02 | |||||
| Sitting extension | 50.9 | <.001 | 11.4 | 0.001 | 5.6 | 0.001 | |||||
| Standing flexion | 37 | <.001 | 3.88 | 0.054 | 9.17 | <.001 | |||||
aLogarithmic transformation.
Figure 3Evolution of the outcomes over time in both groups, based on the repeated measures analysis (estimated marginal means of transformed variables are presented). (A) Timed Up and Go score. (B) Lying knee flexion. (C) Standing knee flexion. (D) Sitting knee extension. TUG: Timed Up and Go.